Syndrome Guillain-Barré is a neurological disorder in which the immune system attacks a part of our body peripheral nervous system and cause muscle weakness and in its most aggressive form paralysis. According to the Centers for Disease Control and Prevention (CDC), Guillain-Barré syndrome (GBS) is a disorder infrequent and his symptoms usually subside, usually after a few weeks. Most people recover completely, but some suffer nervous system damage long term.
The onset of Guillain-Barré syndrome symptoms can be sudden or appear over days or weeks. The first symptoms are usually muscle weakness and numbness feet or hands, which can quickly spread to the rest of the body. In the most severe cases of Guillain-Barré respiratory muscles until the need for artificial respiration.
What triggers the disease
Although the exact cause of the illness is unknown, about two-thirds of people who develop symptoms do so days or weeks after a gastrointestinal or respiratory illness.
Benefits of the vaccine
“These findings further highlight the benefits of ongoing vaccination programs with mRNA-based vaccines,” said the study’s author, Dr. Anat Arbel from the Lady Davis Carmel Medical Center in Haifa, Israel, who adds: “The results have important clinical and public health implications. “While Guillain-Barré is extremely rare, people should be aware that infection with the coronavirus may increase their risk of developing the disorder, and administration of the mRNA vaccine may reduce the risk,” Arbel says in a statement.
However, the authors point out that the study does not show that coronavirus infection increases the risk of Guillain-Barré or that vaccination reduces the risk. It only shows the association.
Therapy
According to the Guttmann Institute, there is currently no curative treatment for Guillain-Barré syndrome, but there are two procedures which can speed recovery:
- The plasmapheresis (it is a procedure that removes antibodies from the blood).
- The intravenous immunoglobulin (these are healthy antibodies that block disease-causing antibodies).
After overcoming the initial phase, in which the patient is treated and any medical complications are stabilized, it is very important to undergo neurorehabilitation treatment in a specialized center where interdisciplinary work can be done on recovery. those lost functions.
